Navigation Links
Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
Date:8/24/2011

June 30, 2011 compared to € 8.1 million in the same period of 2010. At the same time, general and administrative costs amounted to € 1.8 million in the period ended June 30, 2011 compared to € 1.8 million in the same period of 2010.

Net interest income/(cost) amounted to € 0.0 million for the period ended June 30, 2011, consistent with the € (0.0) million in the same period in 2010.

Cash and cash equivalents amounted to € 9.1 million at June 30, 2010, a decrease of € 8.8 million compared to € 17.9 million at December 31, 2010.  The decrease in cash and cash equivalents mainly stems from the operational cash outflow which amounted to € 8.8 million for the period ended June 30, 2011 (compared to an operating cash outflow of € 8.9 million for the period ended June 30, 2010).

Outlook

The Company's expenditure is expected to reduce in the second half of 2011 as the Company takes steps to extend its cash position into 2012. As AMT has not yet reached the point of generating significant revenues that could fund operations, we continue to explore additional opportunities for funding, including non-dilutive sources, such as grants, and collaborations with partners; AMT also tracks opportunities for raising additional capital in conjunction with its bankers.

Conference call and webcast presentation

AMT will conduct a conference call open to the public today at 3.30 p.m. CET, which will also be webcast. Netherlands dial in: +31 (0)20 707 5503; US dial in: +1 718 247 0884; UK dial in: +44 (0)20 7136 6285. Confirmation Code: 5149966

To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

The archived w
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
2. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
4. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
6. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
7. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
8. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
9. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
10. Molecular sleuths track evolution through the ribosome
11. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... natural and synthetic processes prefer to settle into ... energyit is within the realm of non-equilibrium conditions ... changes in energy and phases, such as temperature ... allow humans to regulate their body temperature, airplanes ... seismic activity. , But even though these ...
(Date:7/24/2014)... 2014 SRI International has been awarded a ... of Allergy and Infectious Diseases (NIAID), part of the ... potential therapies for HIV infection and AIDS. The contract ... AIDS and the complications and opportunistic infections associated with ... transmission of HIV. According to the ...
(Date:7/24/2014)... LANSING, Mich. , July 24, 2014  Neogen ... today that future forecasts of its potential revenue from ... conference call to investors and analysts on July 22, ... questioned by analysts regarding this research. "It ... answer questions about the potential of a new type ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that for ... 17 different countries will converge on the Draper ... for an intensive, experiential program focused on entrepreneurship, ... highly selective school, currently running its sixth cohort, ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... Inc. (OTC Bulletin Board: CARN) said it retained,Milkie/Ferguson ... it in,exploring a range of financial alternatives., ... continuation of our efforts to,thoroughly consider our business ... PhD, chief executive officer of Carrington.,"We have valuable ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today ... present a,company update at the 19th Annual Merrill ... New York City on Wednesday,February 6, 2008 at ... a live audio webcast of the presentation,via the ...
... 30 Phosphagenics,Limited ("Phosphagenics") (ASX: POH, AIM: PSG, ... demonstrating that the,combination of its APA- 01 product ... lipids and inflammatory proteins,involved in the development of ... the study was to determine whether a combination ...
Cached Biology Technology:Carrington Retains Milkie/Ferguson to Explore Financial Alternatives 2BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference 2Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 2Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 3Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 4
(Date:7/24/2014)... NY (July 24, 2014) Scientists at The ... are one step closer to creating a viable ... patient,s own cells. , For the first ... cells lines from skin samples of patients with ... an accelerated protocol to induce these stem cells ...
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... planet,s current biodiversity, the product of 3.5 billion years ... the history of life. But it may be reaching ... scientific literature and analysis of data published in ... the loss and decline of animals is contributing to ... planet,s sixth mass biological extinction event. , Since 1500, ...
Breaking Biology News(10 mins):NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3
... of St Andrews have developed a new method of ... technique, which is cheap and powerful, could have important ... Optical technology has huge potential for novel developments in ... groups in this area. The new method -which involves ...
... University in St. Louis have discovered an entirely new ... in plant flowering and DNA methylation, a key chemical ... headed by Craig Pikaard, Ph, D., Washington University professor ... fourth kind of RNA polymerase found only in plants ...
... University of California, San Diego has discovered a molecule ... toxin, or Bt toxin--a pesticide produced by bacteria and ... crops to ward off insect pests. , Their findings ... to prevent insects, which the researchers believe also possess ...
Cached Biology News:New methods of gene delivery using lasers 2New RNA polymerase discovered in plants 2New RNA polymerase discovered in plants 3UCSD discovery may help extend life of natural pesticide 2UCSD discovery may help extend life of natural pesticide 3
... This benchtop ductless exhaust hood ventilates ... safe indoor release of exhaust. Bonded ... Over 28" of vertical clearance (with ... Includes polypropylene spill tray; options include ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
... modular cleanroom for biological safety labs ... cleanliness (to Class 10/ISO 3) and ... create ultra-smooth surfaces that are easy ... radius corners simplify cleaning. Unique double-wall ...
... These versatile enclosures ... with nitrogen or other ... a low-humidity environment. HEPA ... and ionization modules also ...
Biology Products: